Linde India: The Supreme Court rejected Linde India's appeal against a Securities and Exchange Board of India (SEBI) ...

Among patients with limited-stage small cell lung cancer, the benefits of consolidation Imfinzi were seen across a number of ...

AstraZeneca Pharma India has received approval from the CDSO for the import, sale, and distribution of Durvalumab.

AstraZeneca topped the analyst consensus for net revenue and matched the analyst consensus for core EPS in Q2. See why I ...

The stock is trading above its 5-day, 10-day, 20-day, 30-day, 50-day, 100-day, 150-day, and 200-day simple moving averages ...

Indian shares were flat to slightly higher on Tuesday, with metal, oil/gas and power stocks pacing the gainers. The benchmark ...

The company has received approval to import, sell, and distribute Durvalumab Solution for infusion (Imfinzi) from the Central ...

Billionaire investor George Soros became nearly a household name in the early 1990’s by shorting the British pound and making ...

Today we highlight research findings reported at ESMO 2024, the annual meeting of the European Society of Medical Oncology.

The FDA has approved AstraZeneca's Fasenra for eosinophilic granulomatosis with polyangiitis based on Phase 3 MANDARA trial ...

The MEDIOLA trial evaluated olaparib (Lynparza) and durvalumab (Imfinzi) with or without bevacizumab in recurrent ovarian cancer and showed a 34% response rate with the PARP inhibitor and the PD-L1 ...

Meet the Management at ESMO 2024 Conference September 16, 2024 2:00 PM ETCompany ParticipantsPascal Soriot - Chief ...